thromboprophylaxis

(redirected from thromboprophylactic)

thromboprophylaxis

(throm″bō-prō″fĭ-lak′sĭs) [ thrombo- + prophylaxis]
Any preventive measure or medication that reduces the likelihood of the formation of blood clots.
thromboprophylactic (throm″bō-prō″fĭ-lak′tik), adjective
References in periodicals archive ?
Inappropriate drug prescription was a problem in 11 patients and included the administration of nephrotoxic agents to patients with acute kidney injury in 4 patients, the omission of thromboprophylactic agents or antibiotics in 4 and incorrect dosing in 3.
1 According to some authors thrombophilic markers are not the only criteria for the initiation of thromboprophylactic treatment.
2] partial pressure [down arrow] Table 2 Suggested thromboprophylactic doses of enoxaparin for antenatal and postnatal administration (122) Weight Enoxaparin <50 kg 20 mg daily 50-90 kg 40 mg daily 91-130 kg 60 mg daily 131-170 kg 80 mg daily >170 kg 0.
Care must be taken to fully support the patient's calves in the Lloyd Davies supports, ensuring that thromboprophylactic devices can operate effectively and that all possible measures to prevent compartment syndrome are undertaken (Wilde 2004).
Thromboprophylactic recommendations Low risk No thromboprophylaxis is recommended Moderate An effective form of thromboprophylaxis is recommended.
Varied thromboprophylactic options were evaluated, with emphasis on mechanical prophylaxis through use of pneumatic compression devices.
They concluded that selecting a mechanical thromboprophylactic system was not as important as applying an appropriate protocol for patient use and compliance.
Concurrent use of other thromboprophylactic agents and previous use of nonsteroidal anti-inflammatory drugs (NSAIDs) were allowed.
The increased use of other thromboprophylactic treatments (various forms of heparin and pressure stockings) probably made it difficult for aspirin to produce a marked additional effect that would lower an already low rate of adverse events.
Lipolytic effect of low-molecular-weight-heparin (Fragmin) and heparin/dihydroergotamine in thromboprophylactic doses during total hip replacement.
Only thromboprophylactic therapy in APS has been shown to be of proven benefit in improving subsequent pregnancy outcome.